← Back to Search

Behavioural Intervention

System Identification for Obesity

Phase 2
Recruiting
Research Sponsored by The Miriam Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English language fluent and literate at the 6th grade level
Able to walk 2 city blocks without stopping
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every day during the 52-week system identification experiment
Awards & highlights

Study Summary

This trial aims to use a mathematical model based on control systems engineering to predict weight change during weight loss maintenance. Participants will undergo a 6-month weight loss program and those who lose at least 3

Who is the study for?
This trial is for individuals who are obese and have successfully lost at least 3% of their initial body weight. Participants should be willing to use a smartphone daily for surveys and passive sensing over a period of 12 months.Check my eligibility
What is being tested?
The study tests interventions aimed at maintaining weight loss by focusing on physical activity, sleep, stress, emotion regulation, motivation, self-efficacy, and eating habits. It uses control systems engineering to predict when someone might regain weight.See study design
What are the potential side effects?
Since the interventions involve behavioral changes rather than medication or surgery, side effects may include psychological discomfort from lifestyle adjustments or stress from adherence to new routines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can read and speak English at a 6th grade level or higher.
Select...
I can walk 2 city blocks without needing to stop.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every day during the 52-week system identification experiment
This trial's timeline: 3 weeks for screening, Varies for treatment, and every day during the 52-week system identification experiment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight change
Secondary outcome measures
Affect
Dietary Lapse
Dysregulated Eating
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: System IdentificationExperimental Treatment4 Interventions
All participants who lose at least 3% of their initial body weight will be asked to participate in a system identification experiment every day for 52 weeks.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,412 Total Patients Enrolled
447 Trials studying Obesity
588,938 Patients Enrolled for Obesity
The Miriam HospitalLead Sponsor
238 Previous Clinical Trials
37,295 Total Patients Enrolled
76 Trials studying Obesity
15,140 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall count of individuals actively participating in this medical study?

"Affirmative, details on clinicaltrials.gov confirm the ongoing recruitment for subjects in this research. The trial was initially listed on February 12th, 2024 and last revised on January 29th, 2024. It aims to enroll 180 participants at a single site."

Answered by AI

Are patients currently able to enroll in this ongoing medical study?

"Indeed, information available on clinicaltrials.gov underscores the active recruitment phase of this trial. Initially disclosed on February 12th, 2024, and last revised on January 29th, 2024. The study aims to enroll a total of 180 participants from one designated site."

Answered by AI

Is there an age limit for potential participants under 75 years old in this study?

"To be considered for this research study, individuals aged between 18 and 70 are eligible. It's worth noting that there are separate trials available for participants younger than 18 years old (60 studies) as well as those older than 65 (348 studies)."

Answered by AI

What are the safety considerations of utilizing System Identification in individuals?

"Our team at Power has assigned a safety rating of 2 to System Identification on a scale from 1 to 3. This assessment is based on the fact that this trial belongs to Phase 2, indicating existing data supporting safety measures but lacking evidence regarding efficacy."

Answered by AI
~120 spots leftby Dec 2027